Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs LNT✓SelectedUSD · LNTGSK vs LNT performance historyLatest closeAs of+0.52%11/13
Stock and ETF performance explorer

GSK vs LNT

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,742.6%
LNT return
+3,444.2%
Excess return
-1,701.6%
Maximum drawdown
-55.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioLNTExcessAlpha
1D+0.5%+0.5%0.0%+0.4%
7D+1.1%+1.0%+0.1%+0.8%
30D+6.3%+9.6%-3.3%+3.2%
3M+1.8%+5.4%-3.6%0.0%
6M+1.7%+3.1%-1.5%+0.5%
YTD+6.5%+16.5%-9.9%+1.2%
1Y+9.5%+12.3%-2.8%+5.2%
3Y+65.3%+70.3%-5.0%+37.8%
5Y+43.7%+56.4%-12.7%+21.7%
10Y+104.1%+184.3%-80.2%+40.2%
All+1,742.6%+3,444.2%-1,701.6%+434.1%

Cumulative growth

Daily Returns

Daily percentage return beside LNT.

Daily Out/Under-Performance

Portfolio return minus LNT return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × LNT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded LNT wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling